David Mobley launches Living Journal of Computational Molecular Science

David Mobley launches Living Journal of Computational Molecular Science

PharmSci Professor David L. Mobley, in collaboration with Michael R. Shirts from the University of Colorado, Boulder and Daniel M. Zuckerman from the Oregon Health & Science University, have launched the Living Journal of Computational Molecular Science Journal (LiveCoMS), a peer-reviewed, open-access journal seeking to bring publication of educational, review, and best practices materials into the modern age.

The journal’s goal is to better align academic incentives with the realities of computational work that require development of community resources. “LiveCoMS allows authors to publish their work but then continue its development,” explains Mobley. “We provide a venue where authors can formally publish living documents including tutorials and ‘lessons learned’ articles that are updated on an ongoing basis, but which still have clear authorship.”

As of December 1, 2017, the journal is accepting submissions in the areas of:

  • Best practice guides
  • Perpetual reviews
  • Lessons learned
  • Comparisons of molecular simulation packages

The article submission charge of $100 covers the full costs of peer review and publication. For more information, contact David Mobley at dmobley@uci.edu.

Editorial Board

Share This Post

Share on facebook
Share on linkedin
Share on twitter
Share on email

Subscribe To Our Newsletter

Get updates From the UCI School of Pharmacy and Pharmaceutical Sciences

More To Explore

Oath of a pharmacist
PharmD

UCI Welcomes First PharmD Class at White Coat Ceremony

To wrap up the White Coat Ceremony, Founding Dean Jan Hirsch led the students through the Oath of a Pharmacist and a spirited chant of Zot! Zot! Zot! She also asked the PharmD class to turn and applaud their families, a special moment to recognize the support systems that have helped the students enter the challenging and rewarding career of pharmacy.

0 Shares
Share
Tweet
Share18